Steven Dyson

Chairman
Biochemistry
Unilabs
Italy

Academician Pathology
Biography

Steven holds a BA in Biochemistry from Oxford University and a PhD in Developmental Biology from Cambridge University. Steven Dyson was appointed Chairman of Unilabs’ board on 31st of January 2017. Dr. Steven Dyson is a Partner in the Healthcare team and is based in London. Dr. Steven Dyson is a Partner in the Healthcare team and is based in London.He joined Apax Partners in 2000 and has both led and participated in a number of key deals including Vyaire Medical, Invent Farma/neuraxpharm, GENEX, One Call Care Management, Acelity (formerly KCI), Capio, Unilabs, General Healthcare Group and Zeneus Pharma. Prior to joining Apax Partners, Steven was a consultant with McKinsey & Company. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.

Research Intrest

Biochemistry and Pathology